Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Ataxin 1 anticorps (N-Term)

Cet anticorps Lapin Polyclonal détecte spécifiquement Ataxin 1 dans WB. Il présente une réactivité envers Humain.
N° du produit ABIN5514519

Aperçu rapide pour Ataxin 1 anticorps (N-Term) (ABIN5514519)

Antigène

Voir toutes Ataxin 1 (ATXN1) Anticorps
Ataxin 1 (ATXN1)

Reactivité

  • 76
  • 60
  • 36
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 62
  • 49
  • 1
Lapin

Clonalité

  • 62
  • 50
Polyclonal

Conjugué

  • 43
  • 8
  • 7
  • 7
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Ataxin 1 est non-conjugé

Application

  • 82
  • 41
  • 41
  • 34
  • 33
  • 23
  • 23
  • 23
  • 7
  • 7
  • 6
  • 1
  • 1
Western Blotting (WB)
  • Épitope

    • 28
    • 21
    • 17
    • 11
    • 7
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Séquence

    TAWLPGNPGG RGHGGGRHGP AGTSVELGLQ QGIGLHKALS TGLDYSPPSA

    Purification

    Affinity purified

    Immunogène

    The immunogen is a synthetic peptide directed towards the N terminal region of human ATXN1
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
  • Antigène

    Ataxin 1 (ATXN1)

    Autre désignation

    ATXN1

    Sujet

    The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. The function of the ataxins is not known. This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains 41-81 CAG repeats, compared to 6-39 in the normal allele, and is associated with spinocerebellar ataxia type 1 (SCA1). At least two transcript variants encoding the same protein have been found for this gene.

    Alias Symbols: ATX1, SCA1, D6S504E

    Protein Size: 815

    ID gène

    6310

    NCBI Accession

    NM_000332, NP_000323

    UniProt

    P54253

    Pathways

    Synaptic Membrane
Vous êtes ici:
Chat with us!